Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

12.07
BATS BZX Real-Time Price
As of 2:32pm ET
 -0.165 / -1.35%
Today’s Change
8.67
Today|||52-Week Range
14.55
+12.76%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close12.23
Today’s open12.29
Day’s range12.00 - 12.33
Volume58,487
Average volume (3 months)1,279,610
Market cap$1.3B
Dividend yield--
Data as of 2:32pm ET, 05/25/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+111.32%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio18.9
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.70-5.77%
EBSEmergent BioSolution...-0.12-0.40%
GBTGlobal Blood Therape...-0.35-1.20%
RGENRepligen Corp-0.34-0.87%
Data as of 2:32pm ET, 05/25/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)$0.28
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts